Abstract
Abstract: Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.
Author supplied keywords
Cite
CITATION STYLE
Moser, B., Milligan, M. A., & Dao, M. C. (2022). The Microbiota-Gut-Brain Axis: Clinical Applications in Obesity and Type 2 Diabetes. Revista de Investigacion Clinica; Organo Del Hospital de Enfermedades de La Nutricion. NLM (Medline). https://doi.org/10.24875/RIC.22000197
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.